ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.196,18
0,02%
S&P 500
5.011,12
-0,22%
US Dollar vs BRL
5,243
0,17%
Bitcoin
63.498,38
3,62%
Brent Oil
86,415
-0,66%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Bristol Myers Squibb Co (BMY)

  7. Bristol Myers Squibb Co (BMY) Notícias

BMY Bristol Myers Squibb Co

48,30
0,46 (0,96%)
Após o horário de negociação
Última atualização: 19:01:05
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Bristol Myers Squibb Co BMY NYSE Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,46 0,96% 48,30 19:01:05
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
47,94 47,615 48,405 48,30 47,84
mais cotações »

Notícias Recentes

Data Hora Fonte Título
08/04/202412:30BWKRAZATI (adagrasib) in Combination with Cetuximab..
06/04/202414:15BWBristol Myers Squibb Presents New Interim Long-Term Efficacy..
05/04/202410:05BWU.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s..
02/04/202421:08BWEuropean Commission Expands Approval of Bristol Myers..
02/04/202407:59BWBristol Myers Squibb Releases 2023 Environmental, Social and..
28/03/202417:05BWBristol Myers Squibb Announces Pivotal KRYSTAL-12..
28/03/202417:01BWBristol Myers Squibb Provides Update on the First Phase 3..
28/03/202408:30GLOBEPerspective Therapeutics Provides Recent Business Highlights..
26/03/202415:25BWA Bristol Myers Squibb Expande as Iniciativas de Doações..
26/03/202407:59BWBristol Myers Squibb Expands Health Equity Grant Initiatives..
25/03/202409:00BWBristol Myers Squibb to Present Data at the American College..
20/03/202417:45BWBristol Myers Squibb’s Abecma (idecabtagene vicleucel)..
20/03/202407:59BWBristol Myers Squibb Announces CheckMate -9DW Trial..
19/03/202407:59BWBristol Myers Squibb and Ted Danson Empower Those with..
18/03/202409:44BWBristol Myers Squibb Completes Acquisition of Karuna..
15/03/202419:27BWFDA Advisory Committee Votes in Favor of Bristol Myers..
14/03/202422:35BWU.S. FDA Approves Bristol Myers Squibb’s Breyanzi® as the..
11/03/202417:16BWBristol Myers Squibb to Report Results for First Quarter..
07/03/202416:23BWU.S. Food and Drug Administration Approves Opdivo®..
06/03/202418:17BWBristol Myers Squibb to Participate in Upcoming Investor..
01/03/202418:16BWBristol Myers Squibb Announces Dividend
29/02/202408:59BWBristol Myers Squibb Announces New Data from the Long-Term..
26/02/202418:16BWBristol Myers Squibb to Participate in the TD Cowen 44th..
26/02/202410:35BWBristol Myers Squibb Completes Acquisition of RayzeBio,..
23/02/202408:59BWBristol Myers Squibb Receives Positive CHMP Opinion for..
20/02/202408:59BWU.S. Food and Drug Administration (FDA) Accepts Supplemental..
14/02/202421:57BWBristol Myers Squibb Prices $13 Billion of Senior Unsecured..
14/02/202418:16BWBristol Myers Squibb Recommends Stockholders Reject..
14/02/202408:59BWU.S. Food and Drug Administration Accepts for Priority..
12/02/202408:59BWBristol Myers Squibb and RayzeBio Announce Expiration of HSR..
07/02/202408:59BWBristol Myers Squibb Announces Acceptance of U.S. and EU..
05/02/202411:00BWBristol Myers Squibb Named One of America’s Most JUST..
05/02/202408:59BWBristol Myers Squibb and 2seventy bio Share Update on U.S...
02/02/202408:59BWBristol Myers Squibb Reports Fourth Quarter and Full-Year..
30/01/202408:59BWRegulatory Applications Accepted in the U.S. and Japan for..
27/01/202412:00BWSubcutaneous Nivolumab (nivolumab and hyaluronidase) Shows..
26/01/202409:13BWBristol Myers Squibb Receives Positive CHMP Opinion for CAR..
23/01/202410:30BWBristol Myers Squibb Completes Acquisition of Mirati..
22/01/202419:05BWEight-Year Data for Opdivo (nivolumab) Plus Yervoy..
22/01/202419:00BWOpdivo® (nivolumab) in Combination with CABOMETYX®..
20/01/202412:00BWOpdivo (nivolumab) Plus Yervoy (ipilimumab) Reduced the Risk..
17/01/202408:59BWBristol Myers Squibb Data at ASCO GU 2024 Showcase..
09/01/202408:12IHMARKETNEWSWall Street Highlights: HPE and Juniper Networks in..
08/01/202413:46DJNBristol Myers Reaffirms Long-Term Financial Targets
02/01/202413:28DJNBristol-Myers Squibb on Pace for Largest Percent Increase..
02/01/202408:59BWEuropean Medicines Agency Validates Bristol Myers Squibb’s..
27/12/202308:08IHMARKETNEWSWall Street Highlights: Apple Appeals Watch Ban, Tesla to..
26/12/202312:28DJNTrending: Bristol Myers Squibb to Buy RayzeBio
26/12/202310:04DJNRayzeBio Shares Soar Premarket on Takeover by Bristol Myers
26/12/202309:46DJNBristol Myers Squibb to Buy RayzeBio for $4.1 Billion

Seu Histórico Recente

NYSE
BMY
Bristol Myers Squibb
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados